182781842	182781842	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
49695934	49695934	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
189392	189392	CD	B-NP	O
|	|	CC	I-NP	O
1/13/2000	1/13/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/29/2000	8/29/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/9/2000	11/9/2000	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ADRIAMYCIN	ADRIAMYCIN	NN	B-NP	O
INDUCED	INDUCED	VBD	B-VP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

DIABETES	DIABETES	NNS	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

SARCOIDOSIS	SARCOIDOSIS	NNS	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

LEFT	LEFT	NN	B-NP	O
BREAST	BREAST	NN	I-NP	O
CANCER	CANCER	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
LUMPECTOMY	LUMPECTOMY	NNP	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
X-RAY	X-RAY	NN	I-NP	O
THERAPY	THERAPY	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
CHEMOTHERAPY	CHEMOTHERAPY	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
ADRIAMYCIN	ADRIAMYCIN	NNP	I-NP	O
IN	IN	NNP	I-NP	O
1984	1984	CD	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

DEEP	DEEP	NN	B-NP	O
VENOUS	VENOUS	VBZ	B-VP	O
THROMBOSIS	THROMBOSIS	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

OBSTRUCTIVE	OBSTRUCTIVE	NN	B-NP	O
SLEEP	SLEEP	NN	I-NP	O
APNEA	APNEA	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

STATUS	STATUS	NNP	B-NP	B-protein
POST	POST	NNP	I-NP	I-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARCTIONS	INFARCTIONS	NN	I-NP	I-protein
X	X	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
56-year-old	56-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
Adriamycin	Adriamycin	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
other	other	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
hip	hip	NN	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
issue	issue	NN	I-NP	O
and	and	CC	O	O
which	which	WDT	B-NP	O
prompted	prompt	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
present	present	VB	I-VP	O
to	to	TO	B-PP	O
Onver	Onver	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2000	2000	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
progressively	progressively	RB	B-ADJP	O
lethargic	lethargic	JJ	I-ADJP	O
and	and	CC	O	O
an	an	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
there	there	EX	B-NP	O
revealed	reveal	VBD	B-VP	O
hypoventilation	hypoventilation	NN	B-NP	O
,	,	,	O	O
presumed	presume	VBN	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
46	46	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
D50	D50	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
eventually	eventually	RB	B-VP	O
required	require	VBD	I-VP	O
a	a	DT	B-NP	O
D10	D10	NN	I-NP	O
drip	drip	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
her	her	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
BIPAP	BIPAP	NN	B-NP	B-protein
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
O2	O2	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
seemed	seem	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
baseline	baseline	NN	I-NP	O
respiration	respiration	NN	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
,	,	,	O	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
acute	acute	JJ	I-NP	O
worsening	worsening	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
and	and	CC	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
BIPAP	BIPAP	NN	B-NP	B-protein
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
included	include	VBD	B-VP	O
Adriamycin	Adriamycin	NN	B-NP	O
induced	induced	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
sarcoid	sarcoid	NN	B-NP	O
left	leave	VBD	B-VP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thromboses	thrombos	NNS	I-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	VBD	B-VP	I-protein
myocardial	myocardial	JJ	B-NP	I-protein
infarctions	infarction	NNS	I-NP	I-protein
x	x	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Elavil	Elavil	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Robitussin	Robitussin	NNP	B-NP	O
DM	DM	NNP	I-NP	O
10	10	CD	I-NP	O
ml	ml	NN	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
b.i.d.	b.i.d.	RB	I-ADVP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
,	,	,	O	O
Milk	Milk	NNP	B-NP	O
and	and	CC	O	O
Magnesia	Magnesia	NNP	B-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
tablets	tablet	NNS	I-NP	O
p.r.n.	p.r.n.	RB	B-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
oxycontin	oxycontin	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
12	12	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	B-protein
5-10	5-10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
6	6	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
Prevacid	Prevacid	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
social	social	JJ	I-NP	O
history	history	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
with	with	IN	B-PP	O
family	family	NN	B-NP	O
help	help	NN	I-NP	O
for	for	IN	B-PP	O
daily	daily	JJ	B-NP	O
chores	chore	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Physical	Physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
vital	vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
revealing	reveal	VBG	B-VP	O
temperature	temperature	NN	B-NP	O
96	96	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
93	93	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
115/60	115/60	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
24	24	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
saturations	saturation	NNS	B-NP	O
78	78	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
1.5	1.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
neck	neck	NN	I-NP	O
was	be	VBD	B-VP	O
thick	thick	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
pupils	pupil	NNS	I-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
without	without	IN	B-PP	O
murmur	murmur	NN	B-NP	O
,	,	,	O	O
rub	rub	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallop	gallop	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lungs	lung	NNS	I-NP	O
showed	show	VBD	B-VP	O
good	good	JJ	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
few	few	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
bases	base	NNS	I-NP	O
anteriorly	anteriorly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
non-distended	non-distended	JJ	B-NP	O
and	and	CC	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
firm	firm	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
hypoactive	hypoactive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
showed	show	VBD	B-VP	O
generalized	generalize	VBN	B-NP	O
anasarca	anasarca	NN	I-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
responsive	responsive	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
examination	examination	NN	B-NP	O
.	.	.	O	O

Cranial	Cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
II-XII	II-XII	NN	I-NP	B-protein
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Laboratory	Laboratory	NN	B-NP	O
data	datum	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
sodium	sodium	NN	B-NP	O
140	140	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.7	5.7	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
99	99	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
34	34	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
32	32	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.3	1.3	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
8.2	8.2	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
39.3	39.3	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
241	241	CD	B-NP	I-protein
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
32	32	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	O
65	65	CD	I-NP	O
,	,	,	O	O
LDH	LDH	NN	B-NP	B-protein
717	717	CD	I-NP	I-protein
,	,	,	O	O
CK	CK	NN	B-NP	B-cell_line
436	436	CD	I-NP	I-cell_line
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
5.4	5.4	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
I	I	CD	I-NP	O
0.22	0.22	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.6	0.6	CD	I-NP	O
,	,	,	O	O
direct	direct	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.1	0.1	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
381	381	CD	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
1.8	1.8	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.4	9.4	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
albumin	albumin	NN	B-NP	B-protein
4.1	4.1	CD	I-NP	I-protein
.	.	.	O	O

Urine	Urine	NN	B-NP	O
tox	tox	NN	I-NP	O
screen	screen	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
2.5	2.5	CD	B-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
32.0	32.0	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
D-dimer	D-dimer	NN	B-NP	B-protein
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1000	1000	CD	B-NP	O
.	.	.	O	O

Arterial	Arterial	JJ	B-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
before	before	IN	B-SBAR	O
BIPAP	BIPAP	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
pH	pH	NN	B-NP	O
7.41	7.41	CD	I-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
63	63	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pO2	pO2	NN	B-NP	O
66	66	CD	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
by	by	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
portable	portable	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
hilar	hilar	JJ	I-NP	O
fullness	fullness	NN	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ascites	ascite	NNS	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
KUB	KUB	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
free	free	JJ	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
non-specific	non-specific	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
gas	gas	NN	I-NP	O
pattern	pattern	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
5-10	5-10	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
squamous	squamous	JJ	I-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
voltage	voltage	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Step	Step	NNP	I-NP	O
Down	Down	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
BIPAP	BIPAP	NNP	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
BIPAP	BIPAP	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
diuresed	diurese	VBD	B-VP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
,	,	,	O	O
too	too	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
to	to	TO	B-PP	O
intravenous	intravenous	JJ	B-NP	O
boluses	bolus	NNS	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
of	of	IN	B-PP	O
7	7	CD	B-NP	O
liters	liter	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
ventilatory	ventilatory	JJ	B-NP	O
failure	failure	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
bicarb	bicarb	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
respiratory	respiratory	JJ	B-NP	O
acidosis	acidosis	NN	I-NP	O
and	and	CC	O	O
not	not	RB	B-VP	O
tolerating	tolerate	VBG	I-VP	O
BIPAP	BIPAP	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
spiking	spike	VBG	I-VP	O
temperatures	temperature	NNS	B-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
Swan-Ganz	Swan-Ganz	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
floated	float	VBN	I-VP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
afterload	afterload	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
with	with	IN	B-PP	O
Isordil	Isordil	NN	B-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Diamox	Diamox	NNP	B-NP	O
for	for	IN	B-PP	O
metabolic	metabolic	JJ	B-NP	O
alkalosis	alkalosis	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
worsening	worsen	VBG	I-NP	O
respiratory	respiratory	JJ	I-NP	O
acidosis	acidosis	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
ceftazidime	ceftazidime	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
for	for	IN	B-PP	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
peak	peak	NN	I-NP	O
requirement	requirement	NN	I-NP	O
to	to	TO	B-VP	O
oxygenate	oxygenate	VB	I-VP	O
satisfactorily	satisfactorily	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
for	for	IN	B-PP	O
coag	coag	NN	B-NP	O
negative	negative	JJ	I-NP	O
Staph	Staph	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
levofloxacin	levofloxacin	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
per	per	IN	B-PP	O
recommendation	recommendation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
consultation	consultation	NN	I-NP	O
to	to	TO	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sputum	sputum	NN	I-NP	O
culture	culture	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NNP	I-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
amikacin	amikacin	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
for	for	IN	B-PP	O
double	double	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
for	for	IN	B-PP	O
advanced	advance	VBN	B-NP	O
associated	associate	VBN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
with	with	IN	B-PP	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
slowly	slowly	RB	B-VP	O
improved	improve	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
became	become	VBD	B-VP	O
easier	easy	JJR	B-ADJP	O
to	to	TO	B-VP	O
oxygenate	oxygenate	VB	I-VP	O
her	her	PRP	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
decreasing	decrease	VBG	I-NP	O
fever	fever	NN	I-NP	O
curve	curve	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	ch	JJS	I-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
the	the	DT	B-NP	O
vent	vent	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
trach	trach	NN	I-NP	O
collar	collar	NN	I-NP	O
,	,	,	O	O
following	follow	VBG	B-PP	O
her	her	PRP$	B-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
and	and	CC	I-NP	O
PEG	PEG	NN	I-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
issues	issue	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
have	have	VBP	B-VP	O
included	include	VBN	I-VP	O
hypernatremia	hypernatremia	NN	B-NP	O
,	,	,	O	O
thought	think	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
receiving	receive	VBG	B-VP	O
large	large	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
and	and	CC	O	O
having	have	VBG	B-VP	O
no	no	DT	B-NP	O
access	access	NN	I-NP	O
to	to	TO	B-PP	O
free	free	JJ	B-NP	O
water	water	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
free	free	JJ	B-NP	O
water	water	NN	I-NP	O
boluses	bolus	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
improving	improve	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
an	an	DT	B-NP	O
issue	issue	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
creatinines	creatinine	NNS	B-NP	O
rising	rise	VBG	B-VP	O
as	as	RB	B-ADVP	O
high	high	JJ	I-ADVP	O
as	as	IN	B-PP	O
2.6	2.6	CD	B-NP	O
before	before	IN	B-PP	O
falling	fall	VBG	B-VP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
significant	significant	JJ	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
sarcoid	sarcoid	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
CA	CA	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
biopsy	biopsy	NN	I-NP	O
data	datum	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
transthoracic	transthoracic	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
thickened	thicken	VBN	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
suspicion	suspicion	NN	I-NP	O
for	for	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
was	be	VBD	B-VP	O
fairly	fairly	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
further	further	JJ	B-NP	O
positive	positive	JJ	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
should	should	MD	B-VP	O
arise	arise	VB	I-VP	O
,	,	,	O	O
this	this	DT	B-NP	O
might	might	MD	B-VP	O
require	require	VB	I-VP	O
further	far	JJR	B-NP	O
work-up	work-up	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
required	require	VBN	I-VP	O
several	several	JJ	B-NP	O
blood	blood	NN	I-NP	O
transfusions	transfusion	NNS	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
and	and	CC	I-VP	O
oozing	ooze	VBG	I-VP	O
from	from	IN	B-PP	O
various	various	JJ	B-NP	O
procedure	procedure	NN	I-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
some	some	DT	B-NP	O
guaiac	guaiac	JJ	I-NP	O
positive	positive	JJ	I-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
reticulocyte	reticulocyte	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
4.9	4.9	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
25.7	25.7	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
her	her	PRP$	B-NP	O
reticulocyte	reticulocyte	NN	I-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
1.40	1.40	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
inappropriately	inappropriately	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
iron	iron	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
supplemented	supplement	VBN	I-VP	O
with	with	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Promod	Promod	NN	B-NP	O
protein	protein	NN	I-NP	O
supplements	supplement	NNS	I-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
endocrine	endocrine	JJ	I-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
including	include	VBG	B-PP	O
varying	vary	VBG	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
subcutaneously	subcutaneously	RB	B-ADVP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
insulin	insulin	NN	B-NP	B-protein
drips	drip	NNS	I-NP	I-protein
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
from	from	IN	B-PP	O
bed	bed	NN	B-NP	O
to	to	TO	B-PP	O
chair	chair	NN	B-NP	O
with	with	IN	B-PP	O
assistance	assistance	NN	B-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
tracheostomy	tracheostomy	NN	B-NP	O
and	and	CC	I-NP	O
PEG	PEG	NN	I-NP	O
procedure	procedure	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2000	2000	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Diamox	Diamox	NNP	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
G-tube	G-tube	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
amikacin	amikacin	NN	B-NP	B-protein
600	600	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
q.	q.	NN	I-NP	I-protein
24	24	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
,	,	,	O	O
natural	natural	JJ	B-NP	O
tears	tear	NNS	I-NP	O
two	two	CD	B-NP	O
drops	drop	NNS	I-NP	O
OU	OU	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
ceftazidime	ceftazidime	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
8	8	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
5000	5000	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
,	,	,	O	O
ferrous	ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
G-tube	G-tube	NNP	B-NP	O
t.i.d.	t.i.d.	NNP	I-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
G-tube	G-tube	NN	B-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
105	105	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
b.i.d.	b.i.d.	RB	I-ADVP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	O	O
h.s.	h.s.	NN	B-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
G-tube	G-tube	NNP	B-NP	O
q.i.d.	q.i.d.	NNP	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
0.4	0.4	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
one	one	CD	B-NP	I-protein
tablet	tablet	NN	I-NP	I-protein
sublingual	sublingual	JJ	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
five	five	CD	B-NP	I-protein
minutes	minute	NNS	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
nystatin	nystatin	NN	B-NP	O
suspension	suspension	NN	I-NP	O
5	5	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
instructions	instruction	NNS	I-NP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
swab	swab	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
swish	swish	VB	I-VP	O
and	and	CC	I-VP	O
swallow	swallow	VB	I-VP	O
,	,	,	O	O
omeprazole	omeprazole	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
immediate	immediate	JJ	I-NP	O
release	release	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
therapeutic	therapeutic	JJ	B-NP	O
multivitamin	multivitamin	NN	I-NP	O
one	one	CD	B-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
5	5	CD	B-NP	O
ml	ml	NN	I-NP	O
per	per	IN	B-PP	O
G-tube	G-tube	NN	B-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
G-tube	G-tube	NNP	B-NP	O
q.h.s.	q.h.s.	NNP	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
q.	q.	RB	I-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
instructions	instruction	NNS	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
heparin	heparin	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
10A	10A	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
chronic	chronic	JJ	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Flovent	Flovent	NN	B-NP	O
220	220	CD	I-NP	O
mg	mg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
four	four	CD	B-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Pulmonary	Pulmonary	JJ	I-NP	O
Rehabilitation	Rehabilitation	NN	I-NP	O
program	program	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
U	U	NN	I-NP	B-protein
Of	Of	IN	B-ADVP	I-protein
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
Follow-up	Follow-up	JJ	B-NP	O
care	care	NN	I-NP	O
should	should	MD	B-VP	O
include	include	VB	I-VP	O
monitoring	monitor	VBG	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
with	with	IN	B-PP	O
checking	check	VBG	B-VP	O
heparin	heparin	NN	B-NP	O
factor	factor	NN	I-NP	O
10A	10A	NN	I-NP	O
levels	level	NNS	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
Lovenox	Lovenox	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
satisfactory	satisfactory	JJ	I-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
achieved	achieve	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ronnie	Ronnie	NNP	I-NP	O
G	G	NNP	I-NP	O
Sheldon	Sheldon	NNP	I-NP	O
at	at	IN	B-PP	O
Park	Park	NNP	B-NP	O
as	as	RB	B-ADVP	O
soon	soon	RB	I-ADVP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-NP	O
while	while	NN	I-NP	O
at	at	IN	B-PP	O
Park	Park	NNP	B-NP	O
Cean	Cean	NNP	I-NP	O
Hamppo	Hamppo	NNP	I-NP	O
or	or	CC	O	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
there	there	RB	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
GERARD	GERARD	NNP	B-NP	O
CRIMIN	CRIMIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CH01	CH01	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DANILO	DANILO	NNP	B-NP	O
T.	T.	NNP	I-NP	O
PIZZOLATO	PIZZOLATO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
MS5	MS5	NNP	I-NP	O
PJ511/9831	PJ511/9831	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
70434	70434	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

KQBLET65LJ	KQBLET65LJ	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/8	10/8	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/8	10/8	CD	B-NP	O

